Reply to: Adjuvant treatment options and modalities in pancreatic adenocarcinoma: insights from ESPAC4

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Palmer, Daniel (VerfasserIn) , Jackson, Richard (VerfasserIn) , Springfeld, Christoph (VerfasserIn) , Hackert, Thilo (VerfasserIn) , Michalski, Christoph (VerfasserIn) , Neoptolemos, John P. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: July 1, 2025
In: Journal of clinical oncology
Year: 2025, Jahrgang: 43, Heft: 19, Pages: 2229-2230
ISSN:1527-7755
DOI:10.1200/JCO-25-00333
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1200/JCO-25-00333
Verlag, lizenzpflichtig, Volltext: https://ascopubs.org/doi/10.1200/JCO-25-00333
Volltext
Verfasserangaben:Daniel H. Palmer, Richard J. Jackson, Christoph Springfeld, Thilo Hackert, Christoph W. Michalski and John P. Neoptolemos

MARC

LEADER 00000caa a2200000 c 4500
001 1943015929
003 DE-627
005 20260108180149.0
007 cr uuu---uuuuu
008 251201s2025 xx |||||o 00| ||eng c
024 7 |a 10.1200/JCO-25-00333  |2 doi 
035 |a (DE-627)1943015929 
035 |a (DE-599)KXP1943015929 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Palmer, Daniel  |e VerfasserIn  |0 (DE-588)1381596452  |0 (DE-627)1941263542  |4 aut 
245 1 0 |a Reply to: Adjuvant treatment options and modalities in pancreatic adenocarcinoma  |b insights from ESPAC4  |c Daniel H. Palmer, Richard J. Jackson, Christoph Springfeld, Thilo Hackert, Christoph W. Michalski and John P. Neoptolemos 
264 1 |c July 1, 2025 
300 |a 2 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online erschienen: 31. März 2025 
500 |a Gesehen am 01.12.2025 
700 1 |a Jackson, Richard  |e VerfasserIn  |0 (DE-588)1386212555  |0 (DE-627)194809469X  |4 aut 
700 1 |a Springfeld, Christoph  |d 1972-  |e VerfasserIn  |0 (DE-588)123388910  |0 (DE-627)706281039  |0 (DE-576)293689385  |4 aut 
700 1 |a Hackert, Thilo  |d 1971-  |e VerfasserIn  |0 (DE-588)122158512  |0 (DE-627)70579346X  |0 (DE-576)182659208  |4 aut 
700 1 |a Michalski, Christoph  |d 1977-  |e VerfasserIn  |0 (DE-588)129922250  |0 (DE-627)483655848  |0 (DE-576)297904302  |4 aut 
700 1 |a Neoptolemos, John P.  |e VerfasserIn  |0 (DE-588)172283302  |0 (DE-627)697192954  |0 (DE-576)133150879  |4 aut 
773 0 8 |i Enthalten in  |t Journal of clinical oncology  |d Alexandria, Va. : American Society of Clinical Oncology, 1983  |g 43(2025), 19 vom: Juli, Seite 2229-2230  |h Online-Ressource  |w (DE-627)313116962  |w (DE-600)2005181-5  |w (DE-576)090887018  |x 1527-7755  |7 nnas  |a Reply to: Adjuvant treatment options and modalities in pancreatic adenocarcinoma insights from ESPAC4 
773 1 8 |g volume:43  |g year:2025  |g number:19  |g month:07  |g pages:2229-2230  |g extent:2  |a Reply to: Adjuvant treatment options and modalities in pancreatic adenocarcinoma insights from ESPAC4 
787 0 8 |i Ergänzung zu  |a Güzel, Halil Göksel  |t Adjuvant treatment options and modalities in pancreatic adenocarcinoma: insights from ESPAC4, in: Journal of clinical oncology  |d 2025, volume 43, issue 19  |g 2228  |o 10.1200/JCO-24-02707 
856 4 0 |u https://doi.org/10.1200/JCO-25-00333  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext  |7 1 
856 4 0 |u https://ascopubs.org/doi/10.1200/JCO-25-00333  |x Verlag  |z lizenzpflichtig  |3 Volltext  |7 1 
951 |a AR 
992 |a 20251201 
993 |a Article 
994 |a 2025 
998 |g 172283302  |a Neoptolemos, John P.  |m 172283302:Neoptolemos, John P.  |d 910000  |d 910200  |e 910000PN172283302  |e 910200PN172283302  |k 0/910000/  |k 1/910000/910200/  |p 6  |y j 
998 |g 129922250  |a Michalski, Christoph  |m 129922250:Michalski, Christoph  |d 910000  |d 910200  |d 50000  |e 910000PM129922250  |e 910200PM129922250  |e 50000PM129922250  |k 0/910000/  |k 1/910000/910200/  |k 0/50000/  |p 5 
998 |g 122158512  |a Hackert, Thilo  |m 122158512:Hackert, Thilo  |d 50000  |e 50000PH122158512  |k 0/50000/  |p 4 
998 |g 123388910  |a Springfeld, Christoph  |m 123388910:Springfeld, Christoph  |d 910000  |d 910100  |d 50000  |e 910000PS123388910  |e 910100PS123388910  |e 50000PS123388910  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 3 
999 |a KXP-PPN1943015929  |e 4818199486 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"subtitle":"insights from ESPAC4","title_sort":"Reply to: Adjuvant treatment options and modalities in pancreatic adenocarcinoma","title":"Reply to: Adjuvant treatment options and modalities in pancreatic adenocarcinoma"}],"note":["Online erschienen: 31. März 2025","Gesehen am 01.12.2025"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"person":[{"display":"Palmer, Daniel","family":"Palmer","given":"Daniel","role":"aut"},{"family":"Jackson","role":"aut","given":"Richard","display":"Jackson, Richard"},{"family":"Springfeld","given":"Christoph","role":"aut","display":"Springfeld, Christoph"},{"display":"Hackert, Thilo","given":"Thilo","role":"aut","family":"Hackert"},{"display":"Michalski, Christoph","given":"Christoph","role":"aut","family":"Michalski"},{"given":"John P.","role":"aut","family":"Neoptolemos","display":"Neoptolemos, John P."}],"relHost":[{"recId":"313116962","physDesc":[{"extent":"Online-Ressource"}],"disp":"Reply to: Adjuvant treatment options and modalities in pancreatic adenocarcinoma insights from ESPAC4Journal of clinical oncology","origin":[{"publisher":"American Society of Clinical Oncology ; Lippincott Williams & Wilkins","publisherPlace":"Alexandria, Va. ; Baltimore, Md. [u.a.]","dateIssuedKey":"1983","dateIssuedDisp":"1983-"}],"title":[{"subtitle":"JCO : an American Society of Clinical Oncology journal","title_sort":"Journal of clinical oncology","title":"Journal of clinical oncology"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"note":["Fortsetzung der Druck-Ausgabe","Gesehen am 22.05.23"],"titleAlt":[{"title":"official journal of the American Society of Clinical Oncology"},{"title":"JCO"},{"title":"Journal of clinical oncology legacy archive (ASCO)"}],"pubHistory":["1.1983 -"],"corporate":[{"role":"isb","display":"American Society of Clinical Oncology"}],"id":{"issn":["1527-7755"],"eki":["313116962"],"zdb":["2005181-5"]},"part":{"issue":"19","text":"43(2025), 19 vom: Juli, Seite 2229-2230","extent":"2","pages":"2229-2230","volume":"43","year":"2025"}}],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"July 1, 2025"}],"recId":"1943015929","physDesc":[{"extent":"2 S."}],"id":{"eki":["1943015929"],"doi":["10.1200/JCO-25-00333"]},"name":{"displayForm":["Daniel H. Palmer, Richard J. Jackson, Christoph Springfeld, Thilo Hackert, Christoph W. Michalski and John P. Neoptolemos"]}} 
SRT |a PALMERDANIREPLYTOADJ1202